VA.
LRFS | DSS | OS | DFS | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
HR | p | 95% CI | HR | p | 95% CI | HR | p | 95% CI | HR | p | 95% CI | |
Nearest microscopic margin on the specimen (mm) as continuous | 0.82* | 0.057 | 0.68-1.00 | |||||||||
Frankly infiltrated margin HE sect | 2.26** | 0.043 | 1.02-4.96 | |||||||||
Grading (continuous) | 1.65^ | 0.008 | 1.14-2.40 | |||||||||
TNM stage (III-IV vs I-II) | 2.79^ | 0.009 | 1.29-6.00 | |||||||||
pT (classes 3-4 vs classes 1-2) | 2.43** | 0.017 | 1.17-5.07 | 1.91^ | 0.035 | 1.05-3.48 | 1.80° | 0.054 | 0.99-3.27 | |||
Pathologic lymph nodes with ECS (at least 1 vs none) | 2.3* | 0.039 | 1.04-5.08 | 2.07** | 0.046 | 1.01-4.24 | 2.03° | 0.019 | 1.12-3.66 |
* Adjusted by: previous treatment, fresh specimen evaluation, nearest microscopic margin on the specimen, grading, lymphovascular invasion, perineural invasion, cT, pT.
** Adjusted by: previous treatment, nearest microscopic margin on the specimen, depth of invasion, grading, lymphovascular invasion, perineural invasion, cT, cN, pN, identified lymph nodes, chemotherapy.
^ Adjusted by: depth of invasion, frankly infiltrated margin HE, nearest microscopic margin on the specimen, lymphovascular invasion, perineural invasion, cT, cN, pN, identified lymph nodes, pathologic lymph nodes with ECS.
° Adjusted by: previous treatment, frankly infiltrated margin HE, nearest microscopic margin on the specimen, grading, lymphovascular invasion, perineural invasion, TNM stage, pN, identified lymph nodes, number of pathological lymph nodes.